The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.

about

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

P2860

Q47424027-CA8A7E35-C207-4F89-8AC6-0BFABA3DAAEB Q50716088-869DC945-7E84-4E55-96C7-039294E10792

P2860

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.

Item

http://www.wikidata.org/entity/Q54290307

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The function of a novel immuno ...... chronic lymphocytic leukemia.

@en

The function of a novel immuno ...... chronic lymphocytic leukemia.

@nl

type

Item

label

The function of a novel immuno ...... chronic lymphocytic leukemia.

@en

The function of a novel immuno ...... chronic lymphocytic leukemia.

@nl

prefLabel

The function of a novel immuno ...... chronic lymphocytic leukemia.

@en

The function of a novel immuno ...... chronic lymphocytic leukemia.

@nl

P1476

The function of a novel immuno ...... chronic lymphocytic leukemia.

@en

P2093

Anna Dmoszynska

http://www.w3.org/2001/XMLSchema#string

Irena Frydecka

http://www.w3.org/2001/XMLSchema#string

Maciej Grzywnowicz

http://www.w3.org/2001/XMLSchema#string

Malgorzata Zajac

http://www.w3.org/2001/XMLSchema#string

Paulina Wlasiuk

http://www.w3.org/2001/XMLSchema#string

P2860

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1

Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus

PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis

Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.

P304

2908-2913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1017820

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lidia Karabon

Agnieszka Bojarska-Junak

Waldemar Tomczak

Sylwia Chocholska

Joanna Zaleska

Krzysztof Giannopoulos

Agnieszka Karczmarczyk

Katarzyna Skorka

P577

2015-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25682964

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

lymphocyte

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.

about

P2860

P2860

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921